[Efficacy of Cordichin in recurrent supraventicular tachycardia].
The effectiveness of oral Cordichin, a quinidine-verapamil combination, was evaluated in 11 patients with recurrent supraventricular tachycardias. The mechanism of the tachycardias was either AV nodal re-entry or atrial ectopic as documented by electrophysiologic studies. An arrhythmia suppression or a significant decrease of tachycardia attacks was seen in 8 of 11 patients. In 3 patients there was only a mild effect on the recurrence of tachycardias. Cordichin seems to be a valuable alternative drug in the treatment of paroxysmal supraventricular tachycardias.
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D004338:Drug Combinations / Q000008:administration & dosage / Q000097:blood / Q000627:therapeutic use; D004562:Electrocardiography; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011802:Quinidine / Q000008:administration & dosage / Q000097:blood / Q000627:therapeutic use*; D013607:Tablets; D013614:Tachycardia, Paroxysmal / Q000188:drug therapy*; D014700:Verapamil / Q000008:administration & dosage / Q000097:blood / Q000627:therapeutic use*
D004338:Drug Combinations; D013607:Tablets; C034410:quinidine, verapamil drug combination; D014700:Verapamil; D011802:Quinidine
Zur Wirksamkeit von Cordichin bei rezidivierenden supraventrikulären Tachykardien.